Page 227 - Textbook of Pathology, 6th Edition
P. 227

211











                                                                                                                      CHAPTER 8














           Figure 8.20  Mechanisms of activation of protooncogenes to form growth promoting oncogenes.                Neoplasia


           is increased secretion of  PDGF-β  e.g. in gliomas and  c) Fibroblast growth factor (FGF): Overexpression of HST-1
           sarcomas.                                           protoonogene and amplification of  INT-2  protoonogene
           b) Transforming growth factor-α (TGF-α): Overexpression of  causes excess secretion of FGF e.g. in cancer of the bowel
           TGF-α  gene occurs by stimulation of RAS protooncogene  and breast.
           and induces cell proliferation by binding to epidermal growth  d) Hepatocyte growth factor (HGF): Overexpression by binding
           factor (EGF) receptor e.g. in carcinoma and astrocytoma.  to its receptor c-MET e.g. follicular carcinoma thyroid.


            TABLE 8.4: Important Oncogenes, their Mechanism of Activation and Associated Human Tumours.
              Type                   Proto-oncogene     Mechanism          Associated Human Tumours
           1. GROWTH FACTORS
               i) PDGF-β             SIS                Overexpression     Gliomas, sarcoma
               ii) TGF-α             RAS                Overexpression     Carcinomas, sarcomas
              iii) FGF               HST-1              Overexpression     Bowel cancers
                                     INT-2              Amplification      Breast cancer
              iv) HGF                HGF                Overexpression     Follicular carcinoma thyroid

           2. RECEPTORS FOR GROWTH FACTORS
               i) EGF receptors      ERB B1(HER 1)      Overexpression     Squamous cell carcinoma lung, glioblastoma
                                     ERB B2 (HER 2/neu)  Amplification     Ca breast, ovary, stomach, lungs
               ii) c-KIT receptor    c-KIT              Point mutation     GIST
                 (Steel factor)
              iii) RET receptor      RET                Point mutation     MEN type 2A and type 2B, medullary ca thyroid

           3. CYTOPLASMIC SIGNAL TRANSDUCTION PROTEINS
                 GTP-bound           RAS                Point mutation     Common in 1/3rd human tumours, Ca lung, colon,
                                                                           pancreas
                 Non-receptor tyrosine  BCR-ABL         Translocation      CML, acute leukaemias
                 kinase

           4. NUCLEAR TRANSCRIPTION FACTORS
                 C-MYC               MYC                Translocation      Burkitt’s lymphoma
                 N-MYC               MYC                Amplification      Neuroblastoma, small cell Ca lung
                 L-MYC               MYC                Amplification      Small cell Ca lung
           5. CELL CYCLE REGULATORY PROTEINS
                 Cyclins             Cyclin D           Translocation      Ca breast, liver, mantle cell lymphoma
                                     Cyclin E           Overexpression     Ca breast
                 CDKs                CDK4               Amplification      Glioblastoma, melanoma, sarcomas
   222   223   224   225   226   227   228   229   230   231   232